Book a demo
Research & KnowledgeEvent: September 1, 2026

COLDPLASMATECH published an excerpt from the EWMA โ€ข European Wound Management Association symposium discussing the antimicrobial activity and tissue compatibility of COLDPLASMATECH's COLDPLASMA product.

Published

Signal category

Research & Knowledge

Quote

โ€œIn this excerpt from our EWMA โ€ข European Wound Management Association symposium, Prof. Steven Jeffery, Chief Medical Officer at Pioneer Wound Healing and Lymphoedema Centres and Consultant Burns and Plastic Surgeon, discusses the antimicrobial activity and tissue compatibility of ๐–ช๐—ฃ๐—งยฎ ๐—ฐ๐—ผ๐—น๐—ฑ ๐—ฝ๐—น๐—ฎ๐˜€๐—บ๐—ฎ.โ€

โ€” COLDPLASMATECH team

Company

COLDPLASMATECH

Ranked #1 and #2 for MedTech | Germany's best companies 2020 to 2022 | FOCUS Money

Industry
Medical Device
Location
Greifswald, DE
Company size
23 employees

A Star-Trek like medical device that provides the solution to killing multiresistant bacteria and treating chronic wounds. Coldplasmatech GmbH was founded in June 2015 as a spin-off of the Leibniz Institute for Plasma Science and Technology and has been involved in an approval procedure for its innovative medical products (PlasmaPatch and PlasmaCube) since November 2015. Coldplasmatech has attracted attention on various levels. The start-up was listed top successful German start-up in 2014, 2015 and 2016 and has received numerous awards, amongst them the Invention Award, the Leibniz Founder Prize, the IQ Innovation Award and most recently, the Audience Award at INNOVEIT 2017.

Founded 2015

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

ยฉ 2026 SeedOpsCompany intelligence.

SeedOps.